Pipeline To Product – What Is Driving Cell And Gene Therapy Progress In India?

US-based Colossal Labs has claimed to bring back the dire wolf from extinction. While the science is not as dramatic in India yet, cell and gene therapies are making progress as treatments for cancer and other diseases. Pink Sheet takes a look at what is driving CGT success and growth.

Cell And Gene Therapy Is Picking Up Pace In India
Cell And Gene Therapy Is Picking Up Pace In India (Shutterstock)

On 7 April, Dallas-based US biotech company Colossal Laboratories and Biosciences made headlines by claiming to have brought back the dire wolf from extinction. While there is a debate on the merit of that claim, the company edited 20 loci of a grey wolf genome to make the newborns exhibit dire wolf traits, bringing the scientific spotlight back to gene editing.

The science in India is in no way as dramatic yet, but cell and gene therapies have been making progress for some time now in a country which has a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cell & Gene Therapies

More from Market Access